Insulin glargine biosimilar (Wockhardt)

甘精胰岛素生物类似药 (Wockhardt)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin glargine biosimilar (Wockhardt)
Drug Alias Name甘精胰岛素生物仿制药 (Wockhardt)Glaritus DispoPenGlaritusGlaritus Cart
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2013/01/01
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWockhardt Bio Ag
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AE04
Related LinksN/A